tiprankstipranks
Elevance Health (MX:ELV)
:ELV
Mexico Market
ELV
Elevance Health
RESEARCH TOOLSreports

Elevance Health (ELV) Ratios

0 Followers

Elevance Health Ratios

MX:ELV's free cash flow for Q2 2026 was $0.89. For the 2026 fiscal year, MX:ELV's free cash flow was decreased by $ and operating cash flow was $0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.05 1.24 1.10 0.00 0.00
Quick Ratio
 2.05 1.24 1.10 0.00 0.00
Cash Ratio
 0.31 0.48 0.43 0.00 0.00
Solvency Ratio
 0.07 0.09 0.10 0.11 0.11
Operating Cash Flow Ratio
 0.23 0.21 0.30 0.00 0.00
Short-Term Operating Cash Flow Coverage
 19.90 3.11 2.68 4.30 4.76
Net Current Asset Value
$ -14.23B$ -52.74B$ -54.12B$ -69.52B$ -66.42B
Leverage Ratios
Debt-to-Assets Ratio
 0.25 0.27 0.28 0.23 0.23
Debt-to-Equity Ratio
 0.69 0.76 0.79 0.64 0.67
Debt-to-Capital Ratio
 0.41 0.43 0.44 0.39 0.40
Long-Term Debt-to-Capital Ratio
 0.41 0.42 0.42 0.37 0.38
Financial Leverage Ratio
 2.82 2.77 2.83 2.77 2.84
Debt Service Coverage Ratio
 4.71 3.09 2.55 3.02 3.22
Interest Coverage Ratio
 6.25 5.79 7.50 7.49 8.93
Debt to Market Cap
 0.35 0.42 0.37 0.23 0.20
Interest Debt Per Share
 147.65 156.16 145.52 112.20 104.02
Net Debt to EBITDA
 2.60 2.46 2.33 1.77 1.65
Profitability Margins
Gross Profit Margin
38.95%25.56%27.85%100.00%100.00%
EBIT Margin
3.48%4.07%5.14%5.10%5.40%
EBITDA Margin
3.98%4.85%5.93%6.12%6.47%
Operating Profit Margin
3.51%4.07%5.03%4.50%4.85%
Pretax Profit Margin
2.91%3.37%4.47%4.50%4.85%
Net Profit Margin
2.47%2.84%3.38%3.49%3.76%
Continuous Operations Profit Margin
2.46%2.84%3.38%3.50%3.76%
Net Income Per EBT
84.66%84.38%75.66%77.60%77.55%
EBT Per EBIT
83.01%82.72%88.93%100.00%100.00%
Return on Assets (ROA)
3.93%4.66%5.12%5.50%5.74%
Return on Equity (ROE)
11.24%12.90%14.47%15.23%16.26%
Return on Capital Employed (ROCE)
7.54%7.99%9.12%7.08%7.40%
Return on Invested Capital (ROIC)
6.34%6.65%6.74%319.69%333.60%
Return on Tangible Assets
5.70%6.91%7.82%8.16%8.66%
Earnings Yield
5.59%7.28%6.96%5.45%4.79%
Efficiency Ratios
Receivables Turnover
 8.60 13.07 13.54 9.59 9.76
Payables Turnover
 4.89 8.68 8.10 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 43.30 38.81 33.88 39.31 36.28
Asset Turnover
 1.59 1.64 1.51 1.57 1.52
Working Capital Turnover Ratio
 7.17 59.52 260.59 0.00 0.00
Cash Conversion Cycle
 -32.15 -14.14 -18.10 38.06 37.40
Days of Sales Outstanding
 42.45 27.93 26.95 38.06 37.40
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 74.61 42.07 45.05 0.00 0.00
Operating Cycle
 42.45 27.93 26.95 38.06 37.40
Cash Flow Ratios
Operating Cash Flow Per Share
 34.25 19.34 24.94 34.59 35.00
Free Cash Flow Per Share
 28.86 14.31 19.55 29.03 30.20
CapEx Per Share
 5.39 5.03 5.39 5.56 4.80
Free Cash Flow to Operating Cash Flow
 0.84 0.74 0.78 0.84 0.86
Dividend Paid and CapEx Coverage Ratio
 2.78 1.62 2.10 3.00 3.53
Capital Expenditure Coverage Ratio
 6.35 3.84 4.62 6.22 7.29
Operating Cash Flow Coverage Ratio
 0.24 0.13 0.18 0.32 0.35
Operating Cash Flow to Sales Ratio
 0.04 0.02 0.03 0.05 0.05
Free Cash Flow Yield
7.12%4.08%5.30%6.16%5.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 18.11 13.92 14.29 18.36 20.89
Price-to-Sales (P/S) Ratio
 0.44 0.39 0.49 0.64 0.79
Price-to-Book (P/B) Ratio
 1.98 1.77 2.08 2.80 3.40
Price-to-Free Cash Flow (P/FCF) Ratio
 14.05 24.50 18.87 16.25 16.99
Price-to-Operating Cash Flow Ratio
 11.90 18.12 14.79 13.63 14.66
Price-to-Earnings Growth (PEG) Ratio
 -4.03 -5.70 8.44 5.50 -7.64
Price-to-Fair Value
 1.98 1.77 2.08 2.80 3.40
Enterprise Value Multiple
 13.64 10.51 10.52 12.25 13.81
Enterprise Value
 109.19B 101.50B 110.32B 128.50B 139.84B
EV to EBITDA
 13.64 10.51 10.52 12.25 13.81
EV to Sales
 0.54 0.51 0.62 0.75 0.89
EV to Free Cash Flow
 17.36 31.98 24.23 18.99 19.30
EV to Operating Cash Flow
 14.63 23.66 18.99 15.94 16.65
Tangible Book Value Per Share
 26.16 20.21 4.53 16.37 6.80
Shareholders’ Equity Per Share
 205.98 197.84 177.42 168.64 151.01
Tax and Other Ratios
Effective Tax Rate
 0.16 0.16 0.24 0.22 0.23
Revenue Per Share
 922.96 897.77 759.28 735.14 652.48
Net Income Per Share
 22.78 25.53 25.68 25.69 24.56
Tax Burden
 0.85 0.84 0.76 0.78 0.78
Interest Burden
 0.84 0.83 0.87 0.88 0.90
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.03 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.51 0.76 0.97 1.35 1.40
Currency in USD